Overview

Title

Expressing support for the designation of the last Tuesday of April each year as APOL1-Mediated Kidney Disease (AMKD) Awareness Day.

ELI5 AI

This resolution wants to create a special day every year called "APOL1-Mediated Kidney Disease Awareness Day" to help teach people about a type of kidney problem that affects a lot of people, especially in the Black community. It aims to encourage learning about what causes this disease and suggests testing for certain genes in people who might be more at risk.

Summary AI

H. RES. 1124 is a resolution that supports the creation of “APOL1-Mediated Kidney Disease (AMKD) Awareness Day” on the last Tuesday of April each year. It highlights that kidney disease, particularly AMKD, is a serious health issue affecting many Americans, especially in the Black community. The resolution encourages awareness and education about the genetic factors contributing to AMKD and suggests that individuals with ancestry from Western and Central Africa consider genetic testing for APOL1 gene mutations. Additionally, it emphasizes the need for further research and awareness to address health disparities in kidney disease.

Published

2024-04-09
Congress: 118
Session: 2
Chamber: HOUSE
Status: Introduced in House
Date: 2024-04-09
Package ID: BILLS-118hres1124ih

Bill Statistics

Size

Sections:
1
Words:
226
Pages:
3
Sentences:
6

Language

Nouns: 83
Verbs: 14
Adjectives: 7
Adverbs: 1
Numbers: 6
Entities: 26

Complexity

Average Token Length:
4.03
Average Sentence Length:
37.67
Token Entropy:
4.32
Readability (ARI):
19.37

AnalysisAI

The proposed resolution, House Resolution 1124, seeks to establish the last Tuesday of April each year as "APOL1-Mediated Kidney Disease (AMKD) Awareness Day." This initiative aims to heighten awareness about kidney disease, specifically focusing on APOL1-mediated kidney diseases, which disproportionately affect people with Western and Central African ancestry. The resolution highlights the lack of available treatments and stresses the importance of awareness and early detection through genetic testing.

General Summary of the Bill

The resolution primarily functions as an expression of support rather than a legislative action mandating any legal changes or direct financial implications. It underscores the significant burden kidney disease places on millions of Americans and the healthcare system, mainly impacting Black communities disproportionately. By establishing this awareness day, the resolution seeks to educate the public and encourage those at a higher genetic risk to consider genetic testing as a preventive measure.

Summary of Significant Issues

The resolution does not introduce spending, nor does it propose the allocation of resources, which eliminates potential concerns related to fiscal responsibility. It also avoids complex legal language, making the resolution straightforward and focused on its awareness-raising objective. Consequently, there are no significant issues or concerns regarding wastefulness, favoritism, or ambiguous language identified within the bill.

Public Impact

Broadly, this resolution might enhance public understanding of kidney disease and the specific risks associated with the APOL1 gene mutations. Increased awareness could lead to earlier diagnosis and intervention, potentially reducing the disease's physical, emotional, and financial burdens on individuals and the healthcare system. It also aims to motivate public health initiatives and research efforts by highlighting kidney disease disparities.

Impact on Specific Stakeholders

For people of Western and Central African descent, this resolution could significantly impact personal health decisions and societal perceptions of genetic testing. It encourages these individuals to become informed about their genetic risk factors and to take preventive measures, possibly influencing changes in their healthcare behavior. Additionally, healthcare providers may experience increased demand for information and services related to genetic testing, which can facilitate more proactive healthcare strategies.

By spotlighting the need for further research into APOL1-mediated kidney diseases, the resolution may also impact researchers and pharmaceutical companies by encouraging the development and testing of new treatments. A positive shift toward closing the gap in healthcare disparities might start from the awareness generated through such legislative actions.

Sections

Sections are presented as they are annotated in the original legislative text. Any missing headers, numbers, or non-consecutive order is due to the original text.

Read Opens in new tab

Summary AI

The section shows that the House of Representatives supports creating an "APOL1-Mediated Kidney Disease (AMKD) Awareness Day" to raise awareness about kidney disease, particularly APOL1-mediated kidney diseases. It also encourages people in the U.S., especially those with Western and Central African ancestry, to learn more about the disease and consider genetic testing for APOL1 gene mutations.